{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:43:17Z","timestamp":1790854997737,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","award":["TCRD-TPE-111-07"],"award-info":[{"award-number":["TCRD-TPE-111-07"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","award":["TCRD-TPE-MOST-111-12"],"award-info":[{"award-number":["TCRD-TPE-MOST-111-12"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-JCT 111-17"],"award-info":[{"award-number":["TCMF-JCT 111-17"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMFA 107-01-13(112"],"award-info":[{"award-number":["TCMFA 107-01-13(112"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-303-017-MY3"],"award-info":[{"award-number":["111-2314-B-303-017-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajo.2023.05.007","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:24:10Z","timestamp":1683253450000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients With Chronic Kidney Disease: A Nationwide Population-Based Study"],"prefix":"10.1016","volume":"253","author":[{"given":"Yi-Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-8959","authenticated-orcid":false,"given":"Xiao Chun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7603-0826","authenticated-orcid":false,"given":"Jia-Sin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-0388","authenticated-orcid":false,"given":"Ko-Lin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2023.05.007_bib0001","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.ajo.2023.05.007_bib0002","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.survophthal.2007.08.012","article-title":"What is the present pathogenetic concept of glaucomatous optic neuropathy?","volume":"52","author":"Flammer","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2023.05.007_bib0003","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1038\/s41598-021-86846-3","article-title":"Nationwide glaucoma incidence in end stage renal disease patients and kidney transplant recipients","volume":"11","author":"Moon","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2023.05.007_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.62.6.27","article-title":"Association between chronic renal disease and the risk of glaucoma development: a 12-year nationwide cohort study","volume":"62","author":"Cho","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2023.05.007_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.1997.13.23","article-title":"Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor","volume":"13","author":"Maren","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.007_bib0006","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.13499","article-title":"Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function","volume":"84","author":"Hoffmanova","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.ajo.2023.05.007_bib0007","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjo.87.8.1052","article-title":"Topical dorzolamide and metabolic acidosis in a neonate","volume":"87","author":"Morris","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2023.05.007_bib0008","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/ki.2013.491","article-title":"Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways","volume":"85","author":"Wong","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajo.2023.05.007_bib0009","unstructured":"National Health Insurance Research Database, Taiwan. 2022. Accessed May 12, 2022. http:\/\/nhird.nhri.org.tw\/en\/index.htm."},{"issue":"3","key":"10.1016\/j.ajo.2023.05.007_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","article-title":"Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia","volume":"174","author":"Hsu","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.ajo.2023.05.007_bib0011","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfv085","article-title":"Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis","volume":"30","author":"Kuo","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajo.2023.05.007_bib0012","doi-asserted-by":"crossref","first-page":"17150","DOI":"10.1038\/srep17150","article-title":"Add-on protective effect of pentoxifylline in advanced chronic kidney disease treated with renin-angiotensin-aldosterone system blockade\u2212a nationwide database analysis","volume":"5","author":"Kuo","year":"2015","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajo.2023.05.007_bib0013","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.007_bib0014","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.18632\/oncotarget.23387","article-title":"Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease","volume":"9","author":"Hsu","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.007_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003088-200241030-00004","article-title":"Clinical pharmacokinetics of dorzolamide","volume":"41","author":"Martens-Lobenhoffer","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.007_bib0016","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2023.05.007_bib0017","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2023.05.007_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pa.26.040186.000533","article-title":"Renal calcium metabolism and diuretics","volume":"26","author":"Stier","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"10.1016\/j.ajo.2023.05.007_bib0019","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/archinte.1985.00360100075012","article-title":"Significant metabolic acidosis induced by acetazolamide. Not a rare complication","volume":"145","author":"Heller","year":"1985","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ajo.2023.05.007_bib0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.ki.5002036","article-title":"Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production","volume":"71","author":"Wesson","year":"2007","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ajo.2023.05.007_bib0021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2005070775","article-title":"Endothelin-induced increased nitric oxide mediates augmented distal nephron acidification as a result of dietary protein","volume":"17","author":"Wesson","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajo.2023.05.007_bib0022","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ndt\/gfu388","article-title":"Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR","volume":"30","author":"Wesson","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.007_bib0023","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ajo.2023.05.007_bib0024","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40620-019-00656-5","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.ajo.2023.05.007_bib0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1365-2125.1989.tb03451.x","article-title":"Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans","volume":"27","author":"Sweeney","year":"1989","journal-title":"Br J Clin Pharmacol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423002015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:19:08Z","timestamp":1778635148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423002015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0002939423002015"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients With Chronic Kidney Disease: A Nationwide Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}